05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
This past week, the EEOC withdrew its 1997 policy statement regarding mandatory binding arbitration ...
Read More >
On October 16, 2020, the Securities and Exchange Commission ("SEC") adopted amendments to certain au...
Read More >
Artificial intelligence is a set of code designed to perform specific tasks, including capabilities ...
Read More >
The IRS has published Final Regulations finalizing its prior guidance that partners in a partnership...
Read More >
Responses to Gender Pay Inequity: A Quick World Tour - Most major jurisdictions have pay equity la...
Read More >
Close Call. On November 21, 2019, President Donald Trump signed a continuing resolution to keep the ...
Read More >